Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Share Buyback Programme

24 Mar 2025 10:03

RNS Number : 8717B
Crystal Amber Fund Limited
24 March 2025
 

24 March 2025

 

Crystal Amber Fund Limited

("Crystal Amber Fund", the "Company" or the "Fund")

 

Share Buyback Programme

 

Crystal Amber Fund announces that it intends to conduct on-market purchases to buyback the Company's shares under a share buyback programme. Since 15 December 2023, approximately £13.6 million has been returned to shareholders in share buybacks and in order to continue this and reduce the Company's share capital, from now until 30 June 2025 the Company intends to repurchase ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") up to an aggregate amount of £6 million, but no more than 7,225,770 Ordinary Shares, pursuant to the authority obtained at the Company's annual general meeting on 13 December 2024 (the "Buyback").

 

The Company has appointed Winterflood Securities Limited ("Winterflood") to execute and manage the Buyback and has given an irrevocable instruction to Winterflood to make market purchases of Ordinary Shares on its behalf, independently of the Company. Winterflood will make its trading decisions in relation to the Ordinary Shares independently of and uninfluenced by the Company with such trading decisions being in line with the terms of the Buyback.

 

The maximum price which may be paid by the Company per Ordinary Share shall not be more than the higher of:

a.  105 per cent of the average of the middle market quotations for an Ordinary Share as derived from the AIM market of the London Stock Exchange plc for the five business days immediately preceding the day on which the purchase is made; and

b. the value of an Ordinary Share calculated on the basis of the higher of the price quoted for (i) the last independent trade of and (ii) the highest current independent bid for the Ordinary Shares.

 

Due to the relatively low liquidity in the Ordinary Shares, the Company may purchase Ordinary Shares pursuant to the Buyback on any trading day materially in excess of 25 per cent of the average daily volume, being the limit prescribed pursuant to Article 5(1) of the EU Market Abuse Regulation (2014/596/EU) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR") and accordingly, the Company may not benefit from that exemption.

 

There is no guarantee that the Buyback programme will be implemented in full or that any purchases will be made. The Company reserves the right to bring a halt to the Buyback under circumstances that it deems to be appropriate and in accordance with relevant law and regulation.

 

The Company will make further announcements in due course following any share purchases conducted through the Buyback. Ordinary Shares purchased in the Buyback will be cancelled in due course.

 

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

 

Allenby Capital Limited - Nominated Adviser

Jeremy Porter/ Dan Dearden-Williams

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSRRRVUUOUAR
Date   Source Headline
29th Aug 20255:30 pmRNSTotal Voting Rights
27th Aug 20257:00 amRNSMMI's RESET achieves UK regulator registration
26th Aug 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20257:00 amRNS-RMorphic Medical Inc. appoints new Chief Executive
5th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Aug 20251:14 pmRNSShare Buyback Programme
31st Jul 20255:00 pmRNSTotal Voting Rights
24th Jul 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
24th Jul 20254:20 pmRNSHolding(s) in Company
24th Jul 20259:31 amRNSDirector/PDMR Shareholding
24th Jul 20259:31 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20255:37 pmRNSTransaction in Own Shares and Total Voting Rights
18th Jul 20257:00 amRNSFund update
9th Jul 20255:22 pmRNSTransaction in Own Shares and Total Voting Rights
8th Jul 20254:44 pmRNSHolding(s) in Company
7th Jul 20254:50 pmRNSHolding(s) in Company
3rd Jul 20257:00 amRNSMorphic Medical Inc obtains regulatory approval
2nd Jul 20256:13 pmRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20257:00 amRNSShare Buyback Programme
30th Jun 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20254:58 pmRNSTransaction in Own Shares and Total Voting Rights
26th Jun 20254:55 pmRNSTransaction in Own Shares and Total Voting Rights
25th Jun 20256:21 pmRNSTransaction in Own Shares and Total Voting Rights
24th Jun 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jun 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jun 20255:10 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jun 202510:43 amRNSMonthly Net Asset Value
20th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Jun 20255:08 pmRNSTransaction in Own Shares and Total Voting Rights
18th Jun 20254:22 pmRNSHolding(s) in Company
17th Jun 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20257:00 amRNS2024 AGM Voting Update Statement
13th Jun 20255:37 pmRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20255:23 pmRNSTransaction in Own Shares and Total Voting Rights
9th Jun 20255:35 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20254:44 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 20258:53 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20255:03 pmRNSTransaction in Own Shares and Total Voting Rights
30th May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
29th May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd May 20252:59 pmRNSTransaction in Own Shares and Total Voting Rights
21st May 20255:45 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.